Answers are grounded in this paper and cite their sources.
Accurate assessment of glioblastoma multiforme (GBM) tissue heterogeneity remains challenging because tumor core, infiltrative, margin, necrotic, and adjacent tissue regions can differ substantially in biochemical and electrochemical composition. Here, we evaluate monolayer graphene as a tissue-interfaced Raman transducer for detecting tissue-induced modulation of graphene phonons. Surgically resected glioma specimens were placed in direct contact with chemical vapor deposition (CVD)-grown monolayer graphene, and Raman mapping was used to quantify shifts in the graphene 2D band. Histopathology, performed blinded to Raman analysis, was used to assign tissue regions after Raman acquisition. For GBM specimens, tissue-contacting graphene showed measurable 2D-band shifts of approximately 2.3–5.9 cm −1 , corresponding to estimated n-type carrier densities of approximately −4.4 to −13.5 × 10 12 cm −2 . Histologically confirmed margin tissue and one oligodendroglioma specimen displayed larger 2D-band shifts than the GBM cohort average, indicating that the graphene Raman response is sensitive to tissue-dependent interfacial chemistry. These findings support the use of tissue-interfaced graphene as a label-free platform for probing local electrochemical heterogeneity in glioma specimens. Larger cohorts, rigorous strain/doping deconvolution, and blinded diagnostic validation will be required before diagnostic or intraoperative use can be established.
No takes yet. Share an insight, caveat, or question.
Dixon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: